期刊文献+

糖耐量受损急性冠脉综合征患者血清同型半胱氨酸、C反应蛋白水平的研究

The Study of Serum Homocysteine and C-reactive Protein Levels in Acute Coronary Syndrome Patients with Impaired Glucose Tolerance
暂未订购
导出
摘要 目的探讨同型半胱氨酸、C反应蛋白在不同糖耐量的急性冠脉综合征(ACS)患者血清中的变化及其相关性,以探讨急性冠脉综合征在合并糖耐量受损情况下,促发动脉粥样硬化斑块破裂,引发临床事件的可能机制,为及时、有效地干预糖耐量受损患者急性冠脉事件提供新的评价指标。方法选择急性冠脉综合征(ACS)患者89例,根据不同糖耐量水平分为:对照组-糖耐量正常组(NGT组)(29例);2型糖尿病组(T2DM组)(30例);糖耐量受损组(IGT组)(30例)。分别检测血清中同型半胱氨酸、C反应蛋白水平。结果①与NGT组相比,伴IGT组和T2DM组的ACS患者HCY、CRP显著升高,P<0.05。②T2DM组血清HCY、CRP水平高于IGT组,但无统计学意义(P<0.05);③HCY、CRP与HOMA-IR存在正相关(r值分别是0.328、0.362,P<0.05),HCY、CRP之间存在正相关(r值是0.276,P<0.05)。结论①2型糖尿病与糖耐量受损的ACS患者较糖耐量正常的ACS患者具有更明显的炎症反应。②胰岛素抵抗是引起斑块不稳定性增加的因素之一。③HCY、CRP在ACS合并胰岛素抵抗时呈正相关,共同促进糖耐量受损患者ACS的发生。 Objective To investigate the change and relationship of serum homocysteine(HCY) and c-reactive protein(CRP) levels in acute coronary syndrome(ACS) patient with impaired glucose tolerance(IGT).Methods the levels of HCY and CRP in 89 ACS patients were determined.And the patients were divided into three groups by different glucose tolerance.They are NGT group,IGT group and T2DM group.Results ①Compared with NGT group the levels of HCY and CRP in ACS patients with IGT group and T2DM group were significantly higher.②Although the levels of HCY and CRP in T2DM group were higher than the IGT group,but have no statistically difference(P0.05).③The levels of HCY,CRP and HOMA-IR in ACS patients are closely related.Conclusion ①Inflammation in ACS patient with IGT and T2DM group is more notable than the NGT group.②Insulin resistance is a major factor lead to increase instability of atherosclerosis plaque.③Both HCY and CRP promote the process of ACS.
出处 《中国实验诊断学》 2012年第10期1826-1829,共4页 Chinese Journal of Laboratory Diagnosis
关键词 急性冠脉综合征 同型半胱氨酸 C反应蛋白 2型糖尿病 糖耐量受损 acute coronary syndrome homocysteine c-reactive protein impaired glucose tolerance type 2 diabetes mellitus
  • 相关文献

参考文献7

二级参考文献28

  • 1金雪娟,潘信伟,傅华.高同型半胱氨酸血症-冠心病、脑卒中的又一独立危险因素[J].上海预防医学,2000,12(1):37-39. 被引量:11
  • 2汪迎晖,张步延,黄文增.高半胱氨酸促THP-1巨噬细胞表达单核细胞趋化蛋白-1和辛伐他汀的调节作用[J].中国药科大学学报,2003,34(4):372-374. 被引量:1
  • 3急性心肌梗塞溶栓疗法参考方案(1996年7月修订)[J].中华心血管病杂志,1996,24(5):328-329. 被引量:1319
  • 4Dupuis J,Tardif JC,Cernacek P, et al. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes.The RECIFL trial.Circulation,1999,99:3227-3233.
  • 5Waters DD,Azar RR. Should intensive cholesterol lowering play a role in mangement of acute coronary syndromes? Am J Cardiol, 2000,86[Suppl]:35J-43J.
  • 6Pearson TA,Mensah GA,Alexander RW, et al. Markers of inflammation and cardiovascular disease,application to clinical and public health practice:a statement for healthcare professionals from the centers for disease control and prevention and the American H
  • 7Grundy SM,Benjamin IJ,Burke,GL.et al.Diabetes and cardiovascular disease:a statement for healthcare professionals from the American Heart Association.Circulation 1999;100(10):1134-46
  • 8Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol inAdults.Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,And Treatment of High Blood Cholesterol In Adults (Adult Treatment PanelⅢ).JAMA 2001;285(19):2486-97
  • 9Menotti A,Puddu PE,Lanti M.Comparison of the Framingham risk functionbased coronary chart with risk function from an Italian population study.Eur Heart J 2000;21(5):365-70
  • 10Ouchi N,Kihara S,Arita Y,et al Adipocyte-derived plasma protein,adiponectin,suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages.Circulation 2001;103 (8):1057-63

共引文献304

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部